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ABSTRACT
Objectives To understand the perspectives of people with
severe chronic obstructive pulmonary disease (COPD) as
their illness progresses, and of their informal and
professional carers, to inform provision of care for people
living and dying with COPD.
Design Up to four serial qualitative interviews were
conducted with each patient and nominated carer over
18 months. Interviews were transcribed and analysed
both thematically and as narratives.
Participants 21 patients, and 13 informal carers (a family
member, friend, or neighbour) and 18 professional carers
(a key health or social care professional) nominated by
the patients.
Setting Primary and secondary care in Lothian, Tayside,
and Forth Valley, Scotland, during 2007-9.
Results Eleven patients died during the study period. Our
final dataset comprised 92 interviews (23 conducted with
patient and informal carer together). Severe symptoms
that caused major disruption to normal life were
described, often in terms implying acceptance of the
situation as a “way of life” rather than an “illness.” Patients
and their informal carers adapted to and accepted the
debilitating symptoms of a lifelong condition.
Professional carers’ familiarity with the patients’
condition, typically over many years, and prognostic
uncertainty contributed to the difficulty of recognising
and actively managing end stage disease. Overall,
patients told a “chaos narrative” of their illness that was
indistinguishable from their life story, with no clear
beginning and an unanticipated end described in terms
comparable with attitudes to death in a normal elderly
population.
Conclusions Our findings challenge current assumptions
underpinning provision of end of life care for people with
COPD. The policy focus on identifying a time point for
transition to palliative care has little resonance for people
with COPD or their clinicians and is counter productive if it
distracts from early phased introduction of supportive
care. Careful assessment of possible supportive and
palliative care needs should be triggered at key disease
milestones along a lifetime journey with COPD, in
particular after hospital admission for an exacerbation.
INTRODUCTION
“Well, end stage is from the beginning, isn’t it, to a
certain extent?” [F07.2 Nurse]
Globally, long term conditions such as chronic
obstructive pulmonary disease (COPD) are responsi-
ble for an increasing proportion of deaths.1 Cancer
based palliative care services, predicated on an ability
to predict a terminal phase of disease,2 3 are being
extended to encompass people dying with non-malig-
nant disease.4-6 Prognostic indicators have been devel-
oped to aid identification of people “at risk of dying,”
whose physical, psychological, social, and spiritual
needs can be assessed and their care planned.2 7 There
is concern, however, that the slow physical decline of
patients with COPD, which is punctuated by poten-
tially serious but unpredictable disease exacerbations,
may lead to prevarication rather than provision of anti-
cipatory care.8
About half of patients discharged after a hospital
admission for COPD will die within two years.9 Mar-
kers such as severity of disease, poor nutritional status,
comorbid heart disease, depression, impaired quality
of life, and older age have all been shown to be asso-
ciated with an overall poor prognosis.9 10 Accurate pre-
dictions of life expectancy for individual patients with
COPD, however, remain extremely difficult.7 11 This
difficulty with prognosis is compounded by a tendency
for doctors who are familiar with patients to overesti-
mate survival.12 The only conditionwhere prognosis is
less accurate is dementia.11
People with very severe COPD have a well recog-
nised burden of disabling physical symptoms (espe-
cially breathlessness), compounded by comorbidity,
psychological distress, and social isolation.13-17 Despite
these issues, the needs of these patients are typically
poorly addressed, and many patients have limited
access to specialist palliative care services.13 14 The con-
sultation on a strategy for services for COPD in
England18 and the standards of care for COPD in
Scotland19—which advocate adopting a lifelong
approach to preventing, diagnosing, and providing
care for people with COPD—acknowledge this
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deficiency and prioritise access to improved end of life
care for those “sick enough to die.”
To inform current deliberations on how best to pro-
vide care for people living and dying with COPD, we
undertook an in-depth inquiry seeking to understand
the end of life needs of affected patients and their infor-
mal and professional carers.
METHODS
Our study took place over 18 months during 2007-9.
Ethical approval was obtained from the Multicentre
Research Ethics Committee for Scotland (B), and gov-
ernance approval was obtained from NHS Lothian,
NHS Tayside, and NHS Forth Valley.
Longitudinalqualitativeresearchusingmulti-perspective,
serial interviews offers advantages over themore usual sin-
gle “snapshot” qualitative techniques in understanding
patients’ and family carers’ evolving and dynamic experi-
ence of illness (box 1).2021 In this study, we invited patients
andtheirnominatedinformalandprofessionalcarerstotake
part in up to four interviews at 6-9 month intervals. Multi-
disciplinary perspectives from the research team, an end of
study workshop, and views of a lay advisory group were
used to ensure breadth of interpretation of the data.22
Patient recruitment
Primary and secondary care clinicians from general
practices (recruited through the Scottish Primary
CareResearchNetwork) or fromhospital and commu-
nity specialist respiratory services in Lothian, Tayside,
and Forth Valley, Scotland, identified patients with
end stage COPD. We provided information about
the known predictors of a poor prognosis to aid identi-
ficationof suchpatients,7 but specifically suggested that
they should use the “surprise question”—“Would I be
surprised if my patient were to die in the next
12 months?”8—to identify potential participants. We
purposefully sampled to recruit men and women with
different ages, social class, rurality, presence of an
informal carer within the home, and current smoking
status. Significant comorbidity was expected; the only
exclusion criteria were inability to participate (for
example, because of dementia) or other imminently
life threatening illness (for example, lung cancer). A
clinical assessment by a respiratory nurse established
eligibility, indicators of severity, andmarkers known to
be associated with poor prognosis.7
Recruitment of an “interview set”
At each timepoint, patients nominated for interviewan
informal carer (for example, a family member, friend,
or neighbour), if they had one, and a key health or
social care professional whom they regarded as impor-
tant to their care at that time, thereby creating “inter-
view sets.” The person(s) nominated could differ at
different time points. Our previous studies suggested
a sample of 16-20 interview sets would be sufficient to
reach data saturation.20
Consent
Informed written consent was obtained from all
patients at the beginning of the study and reviewed
verbally before each interview. Informal and profes-
sional carers identified by the patient were asked inde-
pendently for their consent to participate. Withdrawal
of a patient’s consent terminated the interview set. If an
informal or professional carer withdrew, interviews
were allowed to continue with other members of the
interview set.
Data generation
A social scientist (MK) carried out the interviews with
patients and informal carers at a location of their
choice, and with professional carers by phone. In-
depth interviews with the patient and his or her infor-
mal carers (jointly, if preferred by the patient) were
participant led, allowing people to tell their story in
their own terms and at their own pace. Issues covered
included the experience of living with COPD, the
patient’s main concerns (whether physical, psycholo-
gical, social, or spiritual), views on care and treatment,
and carers’ needs and concerns (for topic guides see
web appendix 1 on bmj.com). Interviews lasted
between 40 and 150 minutes and were all audio
recorded, with consent. Field notes were recorded
after each interview.
Health and social care professionals were asked
about their perception of the patients’ and informal
carers’ needs, available services, and barriers to the
provision of care. Bereavement interviews were,
where possible, conductedwith both informal and pro-
fessional carers. As we came to appreciate the effect of
the very long disease trajectory of COPD,we used sub-
sequent interviews specifically to explore the patients’
“story” of their condition.
Box 1: Features of serial multi-perspective interviews20
Advantages
 Give important insights into patients’ changing experiences over the course of an
illness
 Enable an understanding of relationships and dynamics between patients, their
families, and their professional carers
 Enable an exploration of similarities and differences in the perceptions of patients and
their family and professional carers
 Enable an understanding of (potentially contrasting) individual needs of patients,
informal carers, and professional carers
 Facilitate integration of suggestions for improving services from patients, informal
carers, and professional carers
 Allow the development of a relationship between the patient and the researcher as a
result of increased contact with participants, which facilitates discussion of sensitive
issues
Disadvantages
 Increased complexity of recruitment
 Need to be sensitive to the disadvantages (as well as the advantages) if the patient
opts for a joint interview with their informal carer
 Potential for breaches of confidentiality if information from one informant is
(inadvertently) relayed to another
RESEARCH
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Data analysis
Interviews were transcribed and managed with a qua-
litative data software programme (QSRNVivo version
7; QRS International, Doncaster, Australia). Analysis
was iterative throughout the study, which allowed
emerging themes to be explored in later interviews;
deviant cases were actively sought. The interviews
with individual patients, informal carers, and profes-
sional carers were coded separately and then analysed:
(a) as serial interviews with individual patients and
carers to identify how needs evolved over time; (b) as
integrated “patient/informal carer/professional carer”
interview sets; and (c) as integrated “patient sets,”
“informal carer sets,” and “professional carer sets.”
Comparing and contrasting across and within these
data sets highlighted emerging themes and, impor-
tantly, also divergence of perspectives.20
All transcripts were coded by MK (assisted by the
study administrator), using a thematic narrative
approach,23 reflecting the research questions and
themes raised by the participants. We used categories
informed by sociological theory on health and illness,
such as Bury’s work on biographical disruption (see
web appendix 2 on bmj.com).24 Frank’s typology of ill-
ness narratives was used to categorise patients’ narra-
tives into three types: restitution, quest, or chaos
(box 2).25 Restitution narratives are satisfactory stories
of illness and recovery. Quest narratives tell stories of
determined action and significant events that led to
understanding of an illness, a search for cure, adaptation
todisability, or campaigning to raise awareness orbetter
care for the condition. By contrast, chaos narratives
appear to be a disjointed series of events within which
neither the narrator who is living within the story, nor
the listener, can discern a clear purpose or direction.
The researcher and principal investigator (MK and
HP)met frequently to discuss the emergent findings, to
aid data synthesis and interpretation. In addition, both
the lay advisory group and themulti-disciplinary steer-
ing group regularly reviewed the evolving themes and
thoughts on the illness narratives in the light of their
areas of expertise, knowledge of the literature, and
experience.22
End of study workshop
Tobridge the (typicallywide) gulf between research and
practice, we convened a national multi-disciplinary end
of study workshop to which we invited 27 academics,
policy makers, and government representatives. This
allowed us not only to share and receive critical feed-
back on our preliminary conclusions, but also to raise
awareness of our emerging findings among those
responsible for service planning and provision (see
web appendix 3 on bmj.com). Extensive notes were
made from recordings of the four break-out groups, in
which participants were invited to reflect critically on
the findings and discuss and debate the implications
for policy and practice.
Lay advisory group
We recruited 10 people with COPD from local
“Breathe Easy” groups, a support group network run
by theBritish Lung Foundation for people livingwith a
lung condition and those who look after them. This lay
advisory group, which was facilitated byMK, met reg-
ularly throughout the study to discuss the interview
topics, the emerging findings, and the methods of dis-
seminating the findings (see web appendix 4 on
bmj.com). The comments, suggestions, and percep-
tions of the group were used throughout the iterative
analysis process to aid interpretation. Fourmembers of
the group attended the end of study workshop.
RESULTS
The characteristics of the 21 patients recruited to the
study are given in table 1. Figure 1 gives details of the
92 interviews—23 of the patient interviews included
the informal carer, and seven of the interviews with
professional carers related to more than one patient.
Table 2 explains our convention for describing the
participants.
Overview of findings
The major physical and social problems faced by the
patients and their informal carers, and the considerable
difficulties in accessing appropriate health and social
care services, were expected findings13-17 and will
therefore not be dwelt on in this paper. Rather, we
focus on the reasons underpinning why current strate-
gies for extending palliative care services to people liv-
ing and dyingwithCOPD is proving such a challenge 8
and suggest alternative approaches to the current pol-
icy direction.
Our report is structured under the following themes:
I Acceptance of COPD as “a way of life”
II The story of COPD
Box 2: Frank’s typology of illness narratives
Arthur Frank’s classic text The wounded storyteller: body, illness and ethics (1995)
suggests three main types of illness narrative25
1) Restitution narrative
“Yesterday I was healthy, today I am sick, but tomorrow I will be healthy again”
This narrative recounts a belief in a restoration to health and portrays illness as transitory.
It is the easiest narrative to tell and to hear.
2) Quest narrative
“I have a health problem but I’m using the experience to improve the situation (for myself
or others)”
In this narrative the patient uses the illness experience as an opportunity to embark on a
personal quest; for example, to adjust to life with illness or to improve care and support for
people with a particular condition. This narrative portrays illness as an opportunity to learn
and improve, and is often found in celebrity accounts.
3) Chaos narrative
“This happened. Later on this happened. And also this happened”
This is the least heard narrative because “lived chaos” cannot be told. The story can only
begin to emerge once there is an ability, however tenuous, to stand outside the chaos.
Telling and hearing a chaos narrative is frustrating because it appears disjointed and
without causal sequence or purpose (an anti-narrative).
RESEARCH
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I Acceptance of COPD as “a way of life”
Apparent throughout the patients’ interviews was a
sense of “acceptance” in the face of severe disease
and social difficulties. COPD was something that had
to be coped with “as best you can” [F07.1]. Distressing
breathlessness was accepted as “the way it has worked
out” [F02.1]. Patients did not actively seek out informa-
tion about their condition; indeed several patients indi-
cated that they would “rather not know” [F07.1]. For
many patients their situation was made considerably
worse by unsuitable housing that they seemed power-
less to influence, leaving them to “do the best you can
with what you’ve got” [F02.1].
“Oh I don’t ask for anything do I? So, if I asked I
think I would get, I am quite sure I would because I
do get excellent help from the doctors, so as I say I
don’t ask . . . we manage as we are, yes, but for how
long I don’t know.” [F10.1]
Although this passivity might be construed nega-
tively, or as weary resignation to insurmountable pro-
blems, in some contexts it could also be seen as
representing an appropriate adaptation to a way of life.
Interviewer: “What has helped you most over these
last two years that I’ve been coming to see you?”
Patient F10.4: “Learning to accept it. To stop
fighting against it and just accept it in my mind.”
The only exception was a relatively young patient
with α1 antitrypsin deficiency. He and his wife had
actively searched for information on the internet,
joined a national organisation for people with “Alpha
1,” and campaigned to improve their circumstances.
“I’ve done a lot of shouting at the council for four
years to get re-housed and it didn’t do much. I had
to threaten them with a lawsuit.” [L06.1 wife]
II The story of COPD
An early observation was the contrast between the
chaotic stories told by people with COPD and the
well constructed and rehearsed narratives of people
with, for example, lung cancer.26 Patients with COPD
struggled to tell a coherent illness story distinct from
their life story. These data are summarised in table 3.
A story with no beginning
It proved impossible for our participants to identify a
“beginning” to their COPD story. Some simply
acknowledged that they had “always been bothered”
[L03.1] with symptoms that dated back to their
“younger years” [T06.1]. Others identified amilestone
(for example, point of diagnosis or a severe exacerba-
tion) and used it as a beginning, although it was clear
that disabling symptoms had preceded this beginning
bymany years. A different beginning could be selected
in subsequent accounts, demonstrating the fluidity of
the stories.
Somepatients respondedwithwell structured stories
of unrelated health problems (“I had a major op in the
infirmary . . . They thought I had cancer.” [L04.1]).
Others answered the question of “when?” by explain-
ing “how” smoking or their job had caused the symp-
toms.
Interviewer: “So when did it all start?”
Informal carer T05.1 [wife]: “See he was a smoker . . .”
Patient T05.1: “We used to put that rubber on
carpets and vulcanise it . . . we didn’t realise that we
were inhaling all that smoke.”
The insidious onset and lack of clear beginning to the
disease was echoed by the clinicians, who described a
point of “formal diagnosis of the actual COPD pro-
blem” [F10.1 GP] that was preceded by years of an
“informal” recognition of the developing symptoms.
The exception again was the patient with α1 anti-
trypsin deficiency, who told a dramatic and well
rehearsed story about how the diagnosis was con-
firmed the day before his wedding. Although he
acknowledged that he had been “slowly deteriorating”
Table 1 | Characteristics of the 21 patients with chronic obstructive pulmonary disease
interviewed for the study
Number of patients
Sex (male/female) 14/7
Age (years; mean (SD; range)) 71 (8; 50-83)
Health board
Lothian 8
Forth Valley 7
Tayside 6
Demography*
Inner city 8
Urban 5
Rural 8
Carer
Living with family carer 10
Family carer local 5
No family carer 6
Smoking status
Ex-smoker 16
Smoker 5
Comorbid disease (one or more comorbidity) 19
Clinical history
Duration of symptoms (years; mean (SD)) 18 (8)
Using oxygen at home 9
History of admissions for exacerbations of COPD 13
History of admissions with respiratory failure 6
Severity of COPD
Spirometry FEV1 (litres; mean (SD)) 0.63 (0.24)
Predicted FEV1 (%; mean (SD))† 26 (10)
Oxygen saturation on air (%; mean (SD))‡ 92 (4)
Medical Research Council dyspnoea score (mean (SD))§ 4.6 (0.7)
Impact of disease
St George’s respiratory questionnaire (mean (SD))¶ 75.2 (11.7)
Hospital anxiety and depression scale, anxiety subscore (mean (SD))** 9.4 (4.9)
Hospital anxiety and depression scale, depression subscore (mean (SD)) 10.3 (4.3)
Values are numbers of patients unless otherwise specified. COPD=chronic obstructive pulmonary disease;
FEV1=forced expiratory volume in one second.
*None of the patients were from ethnic minority backgrounds.
†FEV1 <30% predicted is very severe COPD.
‡92% is the threshold for hypoxia.
§Scale 1-5, 5 is most breathless.
¶Scale 0-100, higher scores indicate worse quality of life.
**Scores above 11 indicate considerable anxiety or depression.
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for many years before diagnosis, the story was told as a
sudden disruption to life.
Informal carer L06.1 wife: “Day before the wedding
we found out he was basically a dying man.”
Interviewer: “Good heavens, how awful!”
Patient L06.1: “So my lungs was away and I was 41.
Interviewer: “That must have been a shock.”
Informal carer L06.1 [wife]: “Slightly!”
Patient L06.1: Because I was always active as a
worker like, 18 hours a day sometimes, always busy
then suddenly it was stop, because I couldn’t do it
anymore.”
A middle that is a way of life
Unlike the narratives of people with cancer and heart
failure, where accounts of the period from diagnosis
are characterised by a clear sense of a developing plot
with one event leading to another,26 the patients with
COPD told “chaos narratives” characterised by direc-
tionless stories that were typically indistinguishable
from their life story and natural ageing.
“I fear I am getting worse (which is understandable),
it’s like any other illness. It’s like ageing, you are
getting older and that really is the illness is getting
worse as well.” [F06.1]
The participants told illness narratives about their
exacerbations (for example, being increasingly breath-
less and rushed into hospital) or a referral for assess-
ment for lung transplantation (such as having high
hopes that were dashed after complex assessments at
a distant hospital). Exacerbations were described as
independent episodes interrupting “normal” life;
there was little sense of a linkage, or a developing tra-
jectory. The very slow evolution of COPDmeant that
some participants who had experienced a long interval
between exacerbations were almost able to tell a “res-
titution narrative.” Table 4 shows a restitution narra-
tive told by a 75 year old man [T01] who was able to
describe himself as “well” after several months in
which his very severe COPD was relatively stable.
This is set against a background of a chaos narrative
in which little changes over the 18 month study.
Although clinicians were aware of the chronic dete-
riorating nature ofCOPD, they told a parallel story of a
“way of life” and colluded (at least linguistically) with
the idea that the patient was “well” between exacerba-
tions.
“People like Mr X who doesn’t really bother us that
much, we really only see him when he’s not well.”
[F08.1 GP]
By contrast, the patientwithα1 antitrypsindeficiency
and his wife told a classic “quest” narrative. They knew
and accepted that the story would end in his death, but
were determined to use the intervening time fighting to
improve care for him and others with the condition.
“They’re not interested in people like us, as I say,
well, because we’ve got . . . the wrong illness, the
wrong age, well, they’ve freely admitted he’s too
young!” [L06.3 wife]
An unpredictable and unanticipated end
Patients were aware that their symptoms were severe
and appreciated that the future was uncertain, but—
consistent with the chaos narrative—“the end” was
described in terms reminiscent of a normal expectation
of death rather than as an anticipated consequence of
an unfolding story. In keeping with findings from sur-
veys of attitudes to death among the public in the Uni-
ted Kingdom,27 our participants were aware of their
own mortality (for example, an 85 year old patient
commented that she “did not know” whether she
would still be alive for future interviews[L05.1]).
Death, however, was generally not considered as an
imminent threat, and end of life wishes were generally
not discussed with professional carers, friends, or
family.
“I know when the nurse first said, ‘I’m referring you
to [a day centre run by the local hospice]’ I thought
oh God! This isn’t terminal! Not me!” [T01.3]
In telling the story of an exacerbation, several
patients said “I thought I was going to die” (in the
Table 2 | Conventions for describing patients and interviews
Criterion Example
Patients
Identified by a consecutive study number and the
health board in which they are registered
L = Lothian,
[L01], [L02]F = Forth Valley
T = Tayside
Interviews
Patient interviews identified by the time point at
which the interview took place
1 = Baseline
[T03.1] is Tayside patient 3, baseline
interview
2 = 6 months
3 = 12 months
4 = 18 months
Informal and professional carers’ interviews
indicated with reference to the patient
[F06.3 GP] is the GP nominated by
Forth Valley patient6 at the12month
time point
0
Deaths (n=5)
Patients (n=21)
Patients (n=16)
Patients (n=10)
(2 too ill to be
interviewed)
Spouses (n=10)
(joint interviews with patients)
Daughters (n=1)
Spouses (n=9)
(joint interviews with patients)
Daughters (n=2)
Hospital doctors (n=2)
Respiratory nurses (n=7)
(regarding 10 patients)
Professional carer (n=1)
General practitioners (n=3)
(regarding 4 patients)
Respiratory nurses (n=5)
(regarding 9 patients)
6
12
18
Time point
(months after
recruitment)
Informal carers
(nominated by patient)
Professional carers
(nominated by patient)
Surviving patients
Deaths (n=6)
Spouses (n=2)
(joint interviews with patients)
General practitioners (n=2)
Respiratory nurse (n=1)
(regarding 3 patients)
Bereavement interviews
Wives (n=2), nurses (n=3)
Patients (n=10)
(3 too ill to be
interviewed)
Spouses (n=2)
(joint interviews with patients)
General practitioners (n=3)
Respiratory nurses (n=2)
Fig 1 | Schedule of interviews over the 18 month study
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past tense), but in keepingwith the restitution narrative
of the acute attack, once they were restored to normal
the threat receded. Interestingly, the professional
carers sometimes used language that echoed the
patients’ normalisation of the prospect of death.
“. . . we are all going to die aren’t we? But it is a case
of picking the time and place [to discuss it].” [L06.1
hospital doctor]
Professional carers were aware that patients were
deteriorating, but a transition point for palliative care
was elusive. The uncertain prognosis (“Is this it?
Another year? Three years?” [F09.1 nurse]) was uni-
versally cited as a barrier, but there were other more
subtle influences of particular relevance in the context
of long standing relationships. Some professional
carers struggled with moving from “always being able
Table 3 | The story of COPD: comparing and contrasting perspectives
Patient perspective
Patient perspective: the exception (patient with α1
antitrypsin deficiency) Professional perspective
A story with no beginning Well rehearsed story of a dramatic diagnosis Insidious onset
I’ve had it forever
“How it started is anybody’s guess; there is noway of knowing .
. . so it has always beenmy belief that something happened in
my younger years that started the damage.” [T06.1]
Interviewer: “So when did it start?”
“Um I think I was, I mean I’ve always been bothered with
bronchitis and things like that through my life.” [L03.1]
I’ll tell you about a milestone . . .
“About 18 months ago. It started off as a chest infection that I
couldn’t get rid of. It was going and it sort of cleared up then a
month later it was back again.” [T01.1]
. . . and choose a different milestone in subsequent accounts
“It started when he broke his ribs. He fell off the ladder about
four years ago and broke his ribs and then he got a chest
infection and any time he coughed he broke his ribs again.”
[T01.4 daughter in a joint interview with her father]
I’ll link it with the story of another health problem
“I had a major op in the Infirmary in, 1985 was it? No, no, 94,
93. I had an abscess on the bowel. They thought I had cancer. I
was worried.” [L04.1]
I can’t tell you “when” so I’ll tell you “how”
Interviewer: “So when did it all start?”
“Well first of all it was with smoking. I was a smoker and just
couldn’t stop.” [T02.1]
“See he was a smoker ...” [T05.1 wife]
“We used to put that rubber on carpets and vulcanise it . . . we
didn’t realise that we were inhaling all that smoke.” [T05.1]
A dramatic beginning
“I suppose the first place to start would be in diagnosis, really
wouldn’t it, official diagnosis was August 98.” [L06.1 wife]
“Slowly deteriorating from about 92-93, I started noticing
getting breathless and getting worse and worse. Now I am a
carpet fitter, and Imean a lot of flats and everything, it was up
and down stairs and this is getting worse. I was a smoker but
it never botheredmebefore so I thought I have to stop this, so
I did cut down on cigarettes, went to the doctor and got
inhalers, take that home try that one, try that one notworking,
try that one, changed doctor and that is when in 98 he finally
found out that it was this ‘Alpha 1’ thing. Nothing they could
do for it so that was the day before we got married.” [L06.1]
Interviewer: “Oh my goodness!”
“Day before the wedding we found out he was basically a
dying man.” [L06.1 wife]
Interviewer: “Good heavens, how awful!”
“So my lungs was away and I was 41.”
“Because I was always active as a worker like, 18 hours a day
sometimes, always busy then suddenly it was stop, because I
couldn’t do it anymore.” [L06.1]
Long history
“He has got a huge file because he has been known to us for
quite a long time . . . the first time I met him was 1999 when I
was asked by the GP to go out and do a home visit because he
washaving an exacerbation of COPD . . . but he had been given
a nebuliser by a predecessor, that was in 1996, after he saw
the consultant.” [F09.1 nurse]
Insidious onset preceding diagnosis
“Six or seven years. Six or seven years since it formally
diagnosed the actual COPD problem, so I think I have seen her
more than anybody became . . . initially informally and then
over the years.” [F10.1 GP]
“He was only diagnosed not so long ago, he has probably had
COPD for years but official diagnosis was just about18months
ago, like from the hospital he was diagnosed years ago in the
community but he had a couple of near death experiences and
that was when I got told.” [F07.1 nurse]
A middle that is a way of life Emotional upheaval and a quest A way of life for clinicians?
Part of ageing
“I fear I am getting worse (which is understandable), it’s like
any other illness. It’s like ageing, you are getting older and that
really is the illness is getting worse as well.” [F06.1]
“I’m all right if I sit still. It’s all just part of getting older I
suppose.” [T03.1]
Nothing to be done
“Oh it’s certainly not very pleasant no, but that’s the way it
worked out, you know I tried it, it’s not going to work for me
whatever the reason. There’s nothing can be done.” [F02.1]
Exacerbations are isolated episodes
“Now I’m fine, but I had a bad time over Christmas. I got a chest
infectionat thebeginningofDecember and it tookme till Feb to
shake it off. But no, I’mfine again now. Back tonormal.” [T01.4]
Coming to terms with a long term illness
“Yes, as I say we have been through the whole spectrum of
emotions with it. The denial part is the hard one because . . .
now we can discuss things quite openly without fear of
ornaments getting thrown and things like that but when he
was going through his denial phase, it was all my fault.”
[L06.1 wife]
Quest for information, support, and appropriate care
“After I did the research on the internet we thought, well, we
can’t surely be the only people with this disease, there must
be somebody else out there that we can ask or whatever.”
[L06.1]
“We joined a British based Alpha 1 support group, which is
purely Alpha 1 sufferers and their families, and we went to a
meeting at Swindon a couple of years back.” [L06.1]
“I’ve done a lot of shouting at the council for four years to get
re-housed and it didn’t domuch I has to threaten themwith a
lawsuit.” [L06.1 wife]
Only “ill” with exacerbations
“People like Mr X who doesn’t really bother us that much, we
really only see him when he’s not well.” [F08.1 GP]
An established routine
Interviewer: “I was going to ask youwhether you have talked to
him at all about what might happen in the future and how
things might progress.”
“No, not really. He usually has got his own [agenda in the
consultation]. It’s more reassurance about how he is and
chatting generally and he just likes a bit of social discourse I
think.” [L04.1 GP]
Longstanding relationships
“We know them so well, and we’ve always been able to do
something, and then it’s that part where for the rest literally
what can we do?” [F07.2 nurse]
An uncertain and unlooked for end Discussed and planned for An uncertain and unlooked for end
I don’t know when
Interviewer: “So, I’ll come and see you again in about 6months
time . . .”
“If I am still alive in 6 months time.”
Interviewer: “I hope youwill be, do you think youmight not be?”
“I don’t know.” [L04.1]
Unlooked for
“Even the doctor said that, it won’t get any better. What I
thought, actually I could stay in the same sort of level . . .”
[F07.3]
“So. I certainly don’t think I’m getting any better, but I haven’t
got any worse I don’t think.” [F10.4]
I don’t know when
“‘We can give himmorphine’ [The consultant] said. ‘Now, the
downside of themorphine is it will do one of two things, it will
either be he will just sleep away or it will calm his breathing
down enough to let us start treatment’.” [L06.1 wife]
Planning for the future
“It wasn’t a difficult decision for me actually because having
spoken about it at length before, you know, when he had bad
episodes, about, you know, what we wanted to happen etc.”
[L06.1 wife]
I don’t know when
“Is this it? Another year? Three years?” [F09.1 nurse]
“. . . he has been knocking on deaths door a few times now. I
think the last time he came into the Royal we really didn’t think
he was going to make it through the night, never mind go
home.” [L06.1 hospital doctor]
Unlooked for
“Very occasionally I’ll bring it [death] up but no . . . I don’t think
generally they think they are going to die of that, of COPD.”
[T01.1 nurse]
“. . . we are all going to die aren’t we, but it is a case of picking
the time and place [to discuss it].” [L06.1 hospital doctor]
RESEARCH
page 6 of 10 BMJ | ONLINE FIRST | bmj.com
to do something” to acknowledging “for the rest lit-
erally what can we do?” [F07.2 nurse]. In contrast to
consultations with people with cancer where “I think
it seems to come up more naturally to talk about
[death]” [L03.1GP], a familiar and comfortable pattern
of consulting prevented initiating an unlooked for dis-
cussion about the future.
Interviewer: “I was going to ask you whether you
have talked to him at all about what might happen
in the future and how things might progress?”
Professional carer L04.1 [GP]: “No, not really. He
usually has got his own [agenda in the consultation].
It’s more reassurance about how he is and chatting
generally and he just likes a bit of social discourse I
think.”
Again, an exception was the patient with α1 anti-
trypsin deficiency,whowas one of only twoparticipants
in our study to have discussed the end with his doctors.
He and his wife spoke openly from the very beginning
of the first interview about his death and their plans for
it. When faced with a decision about the use of mor-
phine in a potentially life threatening exacerbation, his
wife referred to their plans for future care.
“It wasn’t a difficult decision for me actually
because having spoken about it at length before,
you know, when he had bad episodes, about, you
know, what we wanted to happen etc.” [L06.1 wife]
End of study workshop: comments on the data
Participants in the end of studyworkshop offered addi-
tional explanations for our observation of acceptance
of the way of life among patients with COPD and
debated the practicalities of providing supportive end
of life care in the context of a condition inwhich it is not
possible to identify a time point for transition to the
palliative care approach (box 3).
DISCUSSION
Summary of findings
The participants in our study described severe symp-
toms that caused major disruption to normal life, but
often in terms implying acceptance of the situation as a
way of life rather than an illness. The chaos narratives
of their disease stories were impossible to distinguish
from their life stories, lacked a clear beginning, andhad
an unpredictable and unanticipated end. Professional
carers’ perspectives echoed this chaos narrative, con-
tributing to the difficulty in defining a point when pal-
liative care might be appropriate. The policy focus on
identifying a time point for transition to palliative care
has little resonance with these accounts from patients,
informal carers, and professional carers, and may be
counterproductive if it distracts professional carers
from timely consideration of providing much needed
supportive care.
Passive acceptance, weary resignation, or comfortable
adaptation?
The social and clinical burden described by our study
participants reflects accounts in the current
literature.13-17 Some researchers have commented on
a sense of “sad resignation”28 and a tendency for people
with COPD to “marginalise” their condition as the
result of “old age.”29 Delegates at the end of study
workshop suggested a range of explanations for this
“passive acceptance,” including “stoicism,” “weary
resignation” after years of futile attempts to improve
their circumstances, “recalibration” analogous to the
response shift recognised in quality of life research,30
or an adaptive coping strategy. Habraken et al attribu-
ted the “silence” of people with end stage COPD to
them considering their limitations as normal and
regarding themselves as ill only during acute
Table 4 | An example of a “restitution narrative” told against a background of a “chaos narrative” in which little changes over the 18 months study
Time point Quotation Context and field notes recorded immediately after the interview
Interview one (May
2007)
“It started off as a chest infection that I couldn’t get rid of. It was going and it sort
of cleared up then a month later it was back again. Then that sort of cleared up
and finally got it cleared up then, but then it was largely my fault because I have
always been one for ‘oh I’ll work it off’: just didn’t work off.”
Interviewer: “What have you been told about your illness, the cause and
treatment, and the progress?”
“Well, I’ve been told; I think I’ve been told what they know, which isn’t really a
great deal considering.”
“I’ve never heard of COPD. I think it’s just a catch all for asthma, bronchitis,
emphysema, and that.”
The episode selected as the beginning of the story was the one that finally
triggered a diagnosis of COPD.
He blames his lifestyle rather than an underlying disease for the slow resolution.
Typically for a chaos narrative, there is a general lack of enquiry about and
“evaluation” of this new diagnosis perhaps because in reality he had been
symptomatic for many years.
Interview two
(November 2007)
“I had been having a lot of chest infections, had two in three weeks, but now I feel
fine again. I am not so tired as I used to be and I am breathing better, not much
but . . . I am getting on better at the gym. I am actually feeling much better.”
The researcher’s field notes record a fragmented conversation in which he was
“trying to give me answers but with no story to give.”
Descriptions of intermittent chest infections interrupt times when he is back to
“normal.”
Interview three (July
2008)
Interviewer: “So how are you?”
“I’m very well. Well, I feel very well. They tell me I’m not.”
Interviewer: “I really just came to catch up with you know, what’s happened since
last time.”
“Well, I’ve improved!”
“Nothing’s changed. Same old same old! And I’m quite happy with that.”
The most positive of the interviews because the patient has not had an
exacerbation for somemonths, allowing him to tell an upbeat public story which is
almost a restitution narrative.
There is, however, a dual narrative: in reality nothing has changed.
Interview four (May
2009)
“Now I’m fine, but I had a bad time over Christmas. I got a chest infection at the
beginning of December and it tookme till Feb to shake it off. But no, I’m fine again
now. Back to normal.”
The field notes describe a “punctured tale of recovery” owing to a troublesome
exacerbation.
At the end of the study the researcher noted “his story is that things are the same
after two years—they are not worse, they are not better either, so now we are back
to the chaos narrative.”
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 7 of 10
exacerbations.31 Our data support this interpretation
and enable us to offer a theoretically based inter-
pretation.
Not so much an illness, more a way of life
In her seminal book Hard earned lives: accounts of health
and illness from East London (1984), Cornwell identifies
three categories of health problems: normal illnesses,
real illnesses, and health problems that are not illnesses
(table 5). 32 Although our study participants all recog-
nised the current “reality” of their illness, the lack of
story, the causal link with lifestyle, and the lifelong tra-
jectory of the disease suggest that, despite the severity
of their symptoms, they classified COPD as a health
problem that is not an illness. Symptoms were
described as stemming from a lifetime of exposure to
fumes, smoking, or both, and breathlessness was con-
sidered “part of getting older.” By contrast, exacerba-
tions were often classified as real illnesses, but once the
acute episode was over patients felt they were “back to
normal.”The only exception was theman with α1 anti-
trypsin deficiency, in whom a genetic cause, a clear
medical diagnosis, a young age, and severe symptoms
signified a real illness.
The lack of biographical disruption
The term “biographical disruption” describes the
major disruptive experience of developing a chronic
illness and the consequent rethinking of a person’s bio-
graphy and self concept.24 33 34 More recently, the idea
of a “biographically anticipated” event35—exemplified
by older peoples’ experience of osteoarthritis36 and
stroke37—considers that for some people in some cir-
cumstances, certain illnesses can be a “normal crisis.”
Our findings extend these concepts by showing that in
a very slowly progressive condition such as COPD,
patients may have no sense of biographical disruption
at all. In such individuals there is no illness narrative
separate from their life narrative—rather, our study
shows that people gradually adjust their sense of self
over the years to fit within the limitations imposed by
the condition.This lackof disruptionmaybe at the root
of the patients’ and carers’ acceptance and passivity,
such that they neither demand nor use services. Clin-
icians, especially those who have a long term relation-
shipwith the patient,may share this passive acceptance
of the patient’s way of life, contributing to the difficul-
ties in identifying a transition point to palliative care.
The lack of a public story
Cancer has a well publicised “public story” in which
death plays a prominent role.38 People with cancer
are aware that they have a potentially fatal condition
and tell a dual narrative of despair (“I’m going to die”)
balanced by hope (“but I might get better”).23 By con-
trast, COPD is a relatively unknown condition—even
the name causes confusion—with no public story to
which patients can relate. As such patients often have
no expectation of death and no despair, and equally no
hope of cure.
Table 5 | Categories of health problems according to Cornwell’s book Hard earned lives: accounts of health and illness from
East London (1984) 32
Features
Normal illnesses Acute conditions that medicine recognises and treats successfully. Childhood ailments and commonplace, relatively minor
infections are typical examples.
Real illnesses Chronic disabling conditions or more severe or life threatening conditions that medicine has a partial ability to treat.
Conditions such as diabetes or epilepsy that have a clear medical diagnosis, a significant effect on the patient, and that
require ongoing treatment are typical of “real illnesses.” Seeking medical advice is thus an appropriate response to having a
real illness.
Health problems that
are not illnesses
Problems associated with normal processes (for example, age related arthritis or hearing loss) or stem from the person’s
lifestyle (e.g. a backache in a man with a heavy job). “Health problems that are not illnesses” are to be “coped with”; seeking
medical advice is not necessarily appropriate.
Box 3: Extracts from the notes for the four multidisciplinary discussion groups at the end
of project workshops
A way of life
“‘Living with COPD’ is a better term. The beginning of the dying process is the first cigarette
in the bicycle shed at the age of 12.” [Group IV]
“No beginning for the healthcare professional, because it is already advanced before the
professional realises there is a story.” [Group II]
“The trajectory—slowly going down. Every time they come out of hospital they go down a
step—it’s not dramatic. Cancer is dramatic; the start to COPD is ‘boring’.” [Group II]
“Earlier diagnosis is making it even harder—very long trajectory.” [Group III]
Passive acceptance
“Are we talking about the professionals or the patients . . .???” [Group II]
“Could be adaptation—a way of dealing with the problem, getting on with their lives
around this problem. Not necessarily a bad thing.” [Group III]
“Key is acknowledgement that one has a health condition that threatens ones life. Patients
with COPD only accepted that they had an illness when they were in hospital or had an
infection—otherwise life was ‘normal.’” [Group I]
Transition to palliative care
“It’s not about transition, it’s about integration.” [Group II]
“The difficult prognosis is a ‘cop out’ because the need is there. Can still support people.”
[Group I]
“At least if they are on the register, someone in the practice is talking to them, whereas
they are forgotten otherwise.” [Group II]
“Might be useful to think of milestones. Hospital admission (or second hospital
admission) is the obvious one—should that trigger a change of gear?” [Group III]
Comparison with cancer care
“Applying the cancer model across the board is inappropriate.” [Group I]
“We have picked up the term ‘palliative care’ from cancer, maybe we need a different
language?” [Group IV]
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Comparison with other illness trajectories
Our findings raise interesting comparisons with other
disease trajectories. COPD has a lifelong trajectory
(effectively from the first exposure to cigarette smoke,
whichmay be in utero),39 and the onset of symptoms is
so insidious as to be imperceptible. In contrast, despite
their chronic nature, most other types of long term
organ failure typically have a relatively acute presenta-
tion (for example, myocardial infarction may present
as heart failure).
Another comparator might be patients who have
congenital conditions. The concept of “continual bio-
graphical revision” has been used to describe how
young people with cystic fibrosis attempt to normalise
their lives,40 although the genetic cause of this disease
and its impact during childhood distinguishes it from
COPD. Morbid obesity, which is caused by lifestyle,
may be a parallel health problem that is not an illness.
The poorly understood disease trajectory of the frail
elderly echoes recent understanding of accelerated
lung ageing in smokers,41 and the biomedical model
of decline in lung function,39 and may resonate best
with the disease trajectory of COPD.
Strengths and limitations of study
Our 21 participants may not fully represent the diver-
sity of people with very severe COPD. In particular,
none was from an ethnic minority background,
although the study cohort encompassed a broad
range of demographic, social, clinical, and healthcare
backgrounds. All our participants were smokers or ex-
smokers, reflecting the profile ofCOPD in theUK, and
it cannot be assumed that their attitudes can be extra-
polated to non-smokers. However, the causal link of
COPD with lifestyle factors described by our partici-
pants encompassed environmental exposure to a
broad range of pollutants as well as smoking. Inter-
viewing patients and informal carers together may
have resulted in perspectives being modified or with-
held; our experienced researcher was aware of this
potential problem and could adopt strategies to enable
independent voices to be heard.20 We were aware that
researchers’ attitudes influence design, data collection,
and analysis of qualitative studies, and used our multi-
disciplinary professional team and lay advisers to
ensure balanced interpretation of the data.22 In addi-
tion, the comments of the delegates at the end of the
study workshop added to our understanding of the
emerging themes and their practical and policy impli-
cations.
Conclusions and policy implications
Our findings challenge current assumptions about
models of care and have two important implications
for clinicians and policy makers. Firstly, our findings
suggest that, in contrast to other conditions, COPD is
perceived as “a way of life” rather than an illness that
disrupts life. This may underpin acceptance of and
adaptation to increasing disability and major health
and social needs, in a lifestyle that has become familiar
over many years to patients, informal carers, and pro-
fessional carers. Recognition by healthcare profes-
sionals of the risk of “passive acceptance”may enable
services to be developed that actively identify and seek
to address needs.
Secondly, current models of palliative care for
non-malignant disease, adapted from the traditional
cancer model, are predicated on an ability to identify
“palliative” patients whose end of life care needs should
then be assessed and addressed (and who in some sys-
tems should eschew curative care3).2 Our data suggest
that a point of transition to palliative care ismeaningless
and impractical inCOPD, a conditionwith no coherent
story and an unanticipated end. Linking palliation of
symptoms and supportive care to identifying a point
of transition thus risks “prognostic paralysis.”8
We therefore propose linking holistic assessments of
supportive and palliative care needs with milestones
throughout the patient’s journey. Suitable milestones
might be diagnosis, retirement on medical grounds,
starting long term oxygen therapy, hospital admission
for an exacerbation of COPD, or (from a clinicians’
perspective) a positive answer to the “surprise”
question.8 The palliative care approach thus becomes
progressively integrated with good care of a lifelong
progressive disabling condition, with palliative care
specialists available to advise on management of intra-
ctable symptoms (especially breathlessness). The his-
torically low profile of COPD and its lack of public
story is a further barrier to effective provision of sup-
portive care. Voluntary organisations may choose to
champion the disease and communicate a story to aid
public understanding of this silent, lifelong, progres-
sively disabling condition.
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easily identified
WHAT THIS STUDY ADDS
In contrast with many other long term conditions, COPD is perceived by patients and their
informal carers as a “way of life”
Patients with COPD tell a “story” of a health problem with no clear beginning, that is
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